Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Clin Infect Dis. 2020 Apr 7;ciaa394. doi: 10.1093/cid/ciaa394. Online ahead of print.

Abstract

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.